Global Digital Biomanufacturing Market Analysis Report 2023-2027 - Partnerships Driving Adoption of Modern Manufacturing Technologies
October 16, 2023 06:58 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology, By Application, By...
China's Position in the Global Biopharmaceutical Manufacturing Industry: 2023 Insights - Navigating the Evolving Landscape
October 13, 2023 04:03 ET
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "China's Position in Global Manufacturing: A Comparison of China's Emerging Position vs Established Regions' Manufacturing Capacity and Production"...
California Biomanufacturing Center Awarded ARPA Grant to Train Biotechnology Workforce
October 10, 2023 11:15 ET
|
California Biomanufacturing Center
The California Biomanufacturing Center said the City of Vacaville awarded it a two-year, $750,000 grant to retrain displaced workers.
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
A Greener Tomorrow: White Biotechnology Market's Rise, Trends, and Projections to 2034
September 25, 2023 05:58 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "The Global Market for White Biotechnology 2024-2034" report has been added to ResearchAndMarkets.com's offering. White biotechnology utilizes...
Dyadic to Present at BioProcess International
September 12, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Cell and Gene Therapy CDMO Market, Focused on AAV, Set to Surge with 24.61% CAGR
August 30, 2023 09:33 ET
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow,...
Global Biomanufacturing Viral Detection Market Set to Surpass $1.15 Billion by 2032, Fueled by Growing Biopharmaceutical Utilization
August 15, 2023 07:28 ET
|
Research and Markets
Dublin, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The "Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User,...
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 09, 2023 16:00 ET
|
Dyadic International, Inc.
Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines Two MoU’s with Fondazione Biotecnopolo di Siena in Italy and Essential Drugs Company Limited...
Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
July 26, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...